Division of Renal Diseases and Hypertension, University of Colorado Health Sciences Center, Aurora, CO, USA.
Clin J Am Soc Nephrol. 2010 Jun;5(6):1123-31. doi: 10.2215/CJN.04300709. Epub 2010 Apr 29.
The incidence and prevalence of ESRD in the United States continues to increase. Currently there are over 26,000 patients maintained on peritoneal dialysis. Mortality rates have fallen over the past several years, but long-term survival remains poor, with only 11% of peritoneal dialysis patients surviving past 10 years. Cardiovascular disease accounts for most deaths, and dialysis patients have many traditional and nontraditional cardiovascular risk factors. Lowering of these risk factors has not resulted in reduced cardiovascular morbidity and mortality in dialysis patients. Maneuvers to improve long-term peritoneal dialysis patient survival must therefore focus on modifiable risk factors including residual renal function, peritoneal membrane integrity, rate of infections, and peritoneal dialysis center size. This article reviews strategies for preserving residual renal function and peritoneal membrane integrity as well as strategies for reducing the rate of infections to enhance long-term survival in peritoneal dialysis patients.
在美国,终末期肾病的发病率和患病率持续上升。目前,有超过 26000 名患者接受腹膜透析治疗。尽管过去几年死亡率有所下降,但长期生存率仍然较差,只有 11%的腹膜透析患者能活过 10 年。心血管疾病是导致大多数患者死亡的原因,而透析患者有许多传统和非传统的心血管危险因素。降低这些风险因素并没有降低透析患者的心血管发病率和死亡率。因此,提高长期腹膜透析患者生存率的措施必须集中在可改变的危险因素上,包括残余肾功能、腹膜完整性、感染率和腹膜透析中心规模。本文回顾了保留残余肾功能和腹膜完整性的策略,以及降低感染率的策略,以提高腹膜透析患者的长期生存率。